Published in Pharma Investments, Ventures and Law Weekly, September 19th, 2004
The new vaccine, which appears promising in preliminary animal studies, may offer a faster and easier way to protect the general population as well as soldiers on the battlefield in the event of a deadly bioterror attack, the researchers said.
The development, a joint project of BD Technologies and the U.S. Army Medical Research Institute of Infectious Disease, was described at the 228th national meeting of the American Chemical Society in Philadelphia.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.